Eli Lilly, a weight loss drug company, is noted for making GLP-1 drugs and is the main competitor for Ozempic, developing a new drug called Retrotide.
Source Post
The reel discusses two companies, Nokia and Eli Lilly, based on Donald Trump's recent statements about what...
BdinvestinggJun 24, 2026
The reel discusses two companies, Nokia and Eli Lilly, based on Donald Trump's recent statements about what stocks to buy. It highlights Nokia's investment in semiconductor testing and packaging, and Eli Lilly's position as a competitor in the weight loss drug market with their new drug 'Retrotide'. The creator suggests listening closely when Trump gives stock recommendations.
Linked Mentions
Tickers discussed in this post
Nokia is investing $30 million to expand its semiconductor testing and packaging operations, and also delving into photonics.
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.